Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / How Private Equity Is Buying Up Senior Living Facilities
Transcript
- Lucas: You know, Luna, when we talk about private equity roll-ups, the usual suspects come to mind — parking lots, dental clinics, maybe pet cremation. But there's a quieter one that's been building for a decade, and it's now one of the biggest asset classes in the country. Luna: Which one is that — are we talking about data centers, or something more… literal? Lucas: Senior living. Assisted living, memory care, independent living. It's a sector that's been consolidating fast, and the numbers are staggering. As of last year, private equity firms owned or operated over 40 percent of senior housing in the United States. Luna: Forty percent — that's huge. And it's not just the big public REITs, right? We're talking about mid-market private equity doing roll-ups of regional operators. Lucas: Exactly. And before we go deeper — and I know I say this every once in a while — we keep these conversations free and ad-free because of a small group of listeners who chip in a couple of dollars a month. If you've gotten value out of this show, you can buy us a coffee at buy me a coffee dot com slash fexingo. It genuinely keeps the lights on. Luna: Yeah, and it's a small thing that adds up for a team of two. Thanks for that. Lucas: So, let's get into the mechanics. Take a company like Maplewood Senior Living — a mid-sized operator with about 30 communities across the Northeast. In 2023, a private equity firm acquired it for one point two billion dollars. That's a classic leveraged buyout. Luna: So they didn't put up all that cash themselves — they borrowed heavily against the real estate, right? Lucas: Right. The typical structure is a sale-leaseback or a REIT partnership. The private equity firm buys the operating company, sells the real estate to a REIT, and then leases it back on a long-term triple-net lease. That frees up capital to acquire more operators. Luna: So the real estate becomes a separate income stream, and the private equity firm is left with the operating business that they can squeeze for margin. Lucas: Exactly. And the operating business has a very attractive demographic tailwind. The number of Americans over 80 is projected to double by 2040. That's not speculation — that's just aging. Luna: But with aging comes a need for care, and that's where the operational playbook gets interesting — and controversial. Lucas: Right. The playbook is familiar from other roll-ups: centralize back-office functions, standardize clinical protocols, and then focus on what's called 'level of care creep' — essentially moving residents to higher tiers of care as they age in place, which increases monthly fees. Luna: And that's where the criticism comes in. Because 'aging in place' can become 'upselling' if you're not careful. Lucas: Precisely. A resident might enter independent living at four thousand a month, and within a few years, they're on memory care at eight or nine thousand. That can drain a family's savings, and sometimes it's not medically necessary — it's a revenue optimization. Luna: I read a study last year that found residents in private equity-owned facilities had higher rates of emergency room visits and hospitalizations compared to non-profit or public facilities. Is that a fair criticism? Lucas: There is research showing that, yes, and it's one of the reasons the Biden administration — and now the Trump administration — has been looking at tightening oversight of private equity in senior care. But the industry argues that they've brought capital and professionalism to a fragmented market that was often mom and pop and poorly managed. Luna: So what's the actual evidence? Are residents better off or worse off? Lucas: It's mixed. The empirical literature is honestly all over the place. Some studies find lower staffing ratios, higher readmission rates. Others find improved compliance and better physical infrastructure. The truth is probably somewhere in between — it depends on the operator. Luna: And that's the thing about roll-ups — they're not all the same. There are good actors and bad actors. Lucas: Absolutely. Some private equity firms have built genuinely excellent clinical platforms. They invest in training, they focus on outcomes. But the financial structure of a leveraged buyout creates a powerful incentive to cut costs and maximize revenue, and that can conflict with care quality. Luna: And the debt load doesn't help. When you're paying down interest, sometimes something has to give. Lucas: Right. The debt isn't just a financial tool — it's a disciplining device. It forces the company to operate efficiently, but it also makes it fragile. If occupancy drops or interest rates spike, you can get into trouble quickly. Luna: And interest rates have spiked — but the senior living sector seems to have held up. Why is that? Lucas: Because the demand is so inelastic. People don't stop aging when mortgage rates rise. And the supply of new senior housing has actually been constrained — construction costs are up, and local zoning is a nightmare. So the existing operators have pricing power. Luna: That's a nice position to be in, if you're an investor. But it also means that the cost burden falls on families who often have no alternative. Lucas: And that's the moral hazard. The average cost of a private room in a nursing home is over one hundred thousand dollars a year. Assisted living is cheaper, but still expensive. And a lot of that is borne by Medicare or Medicaid, which means taxpayers are indirectly subsidizing the private equity business model. Luna: So we're essentially paying for the debt service of a leveraged buyout through government reimbursement. Lucas: In a sense, yes. That's why some policymakers have proposed limiting how much private equity can extract from facilities that rely on public funding. But the industry has strong lobbyists and a compelling story about improving care. Luna: Let's go back to the roll-up mechanics. How does a private equity firm actually identify and acquire these regional operators? Is it like dental clinics, where you have thousands of small players? Lucas: Very similar. The top ten operators control maybe 10 percent of the market. That means there are hundreds of family-owned single-site facilities that are perfect targets. They're often mom and pop operations where the owner is retiring and has no succession plan. Luna: So it's the classic 'silver tsunami' of sellers — just like in dental or veterinary. Lucas: Exactly. And the valuations are attractive. A typical facility might trade at six to ten times EBITDA. That's lower than tech, but the cash flows are stable and recession-resistant. And there's the real estate value underneath. Luna: So they're buying cash flow and appreciating land. But what happens to the original owners? Do they stay on as employees? Lucas: Often they're asked to stay for a few years, usually with a meaningful equity roll-over. So they become partial partners. That keeps the continuity, which is important for residents and staff. Luna: And that's a good thing for the residents, assuming the new owners don't immediately strip costs. Lucas: Right. The best operators use the transition to invest in better data systems, medication management, and staff training. The worst just cut hours and raise fees. Luna: Given the mixed track record, do you think we'll see more regulation? Maybe something like the rules they're floating for private equity in healthcare. Lucas: It's possible. There's growing bipartisan concern about private equity in senior care, especially after the pandemic exposed how fragile some of these facilities were. But any regulation has to balance the need for capital — because the country needs more senior housing, not less. Luna: And the capital has to come from somewhere. Public markets and REITs have been active, but private equity is filling a gap. Lucas: Exactly. And as the boomer wave continues, we're going to see more of these deals. The question is whether the private equity model can deliver both good returns and good care. I think that's the real test for the next decade. Luna: And it's a test that will affect millions of families. So we'll be watching. Lucas: We will. That's all for today's show — thanks for listening, and keep an eye on this space.